These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6433080)

  • 41. Clinical and experimental studies of the determination of serum guanase activity in acute myocardial infarction.
    Ito S; Takaoka T; Kishi S; Nakaya Y; Hiasa Y; Mori H
    Jpn Circ J; 1981 May; 45(5):525-31. PubMed ID: 7230507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of measurement of serum guanase activity as a screening test of liver damage.
    Ito S; Takaoka T; Hirano H; Kishi S; Mori H
    Gastroenterol Jpn; 1981; 16(5):478-92. PubMed ID: 7327386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical picture and outcomes of post-transfusion viral hepatitis non-A, non-B and B].
    Favorov MO; Bugaeva NP; Ketiladze ES
    Sov Med; 1985; (6):97-100. PubMed ID: 3933126
    [No Abstract]   [Full Text] [Related]  

  • 44. [Guidelines for working with blood in Stockholm County].
    Jordemodern; 1986 Jun; 99(6):216-7. PubMed ID: 3091547
    [No Abstract]   [Full Text] [Related]  

  • 45. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 46. Low incidence of post-transfusion hepatitis in patients with liver cirrhosis.
    Watanabe A; Fujiwara M; Kobayashi M; Nakatsukasa H; Higashi T; Hashimoto M; Yamauchi Y; Nagashima H
    Hepatogastroenterology; 1986 Jun; 33(3):95-7. PubMed ID: 3091470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Case of post-transfusion viral hepatitis of the non-A, non-B type].
    Knap J; Karwowska S
    Pol Tyg Lek; 1982 Oct; 37(40):1209-10. PubMed ID: 6819554
    [No Abstract]   [Full Text] [Related]  

  • 48. Reducing hepatitis by testing blood for alanine aminotransferase.
    Kahn RA
    N Engl J Med; 1983 Apr; 308(14):844-5. PubMed ID: 6403860
    [No Abstract]   [Full Text] [Related]  

  • 49. [Guanine and adenosine deaminase activities in blood serum in the course of viral hepatitis].
    Boroń P; Kucharski C; Prokopowicz D; Kossakowski R
    Przegl Lek; 1973; 30(2):277-9. PubMed ID: 4692939
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical characteristics of non-A, non-B viral hepatitis in comparison with other types of viral hepatitis].
    Kikuchi K; Tateda A
    Nihon Rinsho; 1981 Oct; 39(10):3216-25. PubMed ID: 6803019
    [No Abstract]   [Full Text] [Related]  

  • 52. Simple, rapid determination of serum guanase activity with the Hitachi 736 automated discrete analyzer.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Chem; 1985 Jan; 31(1):103-5. PubMed ID: 2981163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple ultraviolet spectrophotometric method for the determination of serum guanase activity.
    Yasmineh WG
    Clin Biochem; 1988 Aug; 21(4):239-43. PubMed ID: 3409526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A sensitive spectrophotometric assay for guanase activity.
    Ando T; Muraoka T; Okuda H
    Anal Biochem; 1983 Apr; 130(2):295-301. PubMed ID: 6869816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guanine deaminase in serum as an indicator of survival probability in severe shock patients.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Chim Acta; 1983 Jun; 131(1-2):67-73. PubMed ID: 6883711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship of serum guanase levels with economic characters in Zebu purebred and temperate x Zebu crossbred dairy cattle.
    Rishi S; Agarwal VK; Anand GR; Agarwal SP; Balaine DS; Dwaraknath PK
    Biochem Genet; 1981 Oct; 19(9-10):987-96. PubMed ID: 7199282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention of post-transfusion non-A, non-B hepatitis].
    Habibi B; Smilovici W
    Rev Fr Transfus Immunohematol; 1988 Oct; 31(3):537-86. PubMed ID: 3144032
    [No Abstract]   [Full Text] [Related]  

  • 58. Transfusion-associated non-A, non-B hepatitis. Where do we go from here?
    Seeff LB; Dienstag JL
    Gastroenterology; 1988 Aug; 95(2):530-3. PubMed ID: 3134271
    [No Abstract]   [Full Text] [Related]  

  • 59. Activation energy, relative substrate specificity and optimum pH of guanase from humanrat, mouse and guinea pig sera and tissues.
    Galanti B; Russo M; Nardiello S; Giusti G
    Enzyme; 1975; 20(2):90-7. PubMed ID: 236181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further observations on the properties of serum and tissue guanase from man and some animal species. Optimum pH and activation energy in the presence of 8-azaguanine.
    Galanti B; Russo M; Nardiello S; Giusti G
    Enzyme; 1976; 21(4):342-8. PubMed ID: 7449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.